At Rush University Medical Center in Chicago, Illinois, we believe that clinical research is the foundation for advances in patient care. Through our leading-edge heart and vascular research program, we are committed to helping patients with heart and vascular diseases by developing new therapies and medical devices, as well as by expanding scientific and medical knowledge.
Over the years, our clinicians have participated in numerous clinical trials aimed at finding effective, less invasive ways to prolong life, relieve symptoms and prevent disease recurrence. Thanks to these research efforts, Rush has been a leader — in Chicago and nationally — in expanding the arsenal of weapons for fighting heart and vascular diseases, including stem cell therapy for both chronic chest pain (angina) and peripheral arterial disease, and novel catheter-based approaches to treating heart valves and blocked arteries without surgery.
See a list of cardiology clinical trials open for enrollment